dc.date.accessioned2022-01-04T20:30:00Z
dc.date.available2022-01-04T20:30:00Z
dc.date.created2022-01-04T20:30:00Z
dc.date.issued2013
dc.identifierhttps://hdl.handle.net/20.500.12866/10512
dc.identifierhttps://doi.org/10.1111/ijcp.12208
dc.description.abstractAims: To implement a patient registry and collect data related to the care provided to people with type 2 diabetes in six specialized centers of three Latin American countries, measure the quality of such care using a standardized form (QUALIDIAB) that collects information on different quality of care indicators, and analyze the potential of collecting this information for improving quality of care and conducting clinical research. Methods: We collected data on clinical, metabolic and therapeutic indicators, micro- and macrovascular complications, rate of use of diagnostic and therapeutic elements and hospitalization of patients with type 2 diabetes in six diabetes centers, four in Argentina and one each in Colombia and Peru. Results: We analyzed 1157 records from patients with type 2 diabetes (Argentina, 668; Colombia, 220; Peru, 269); 39 records were discarded because of data entry errors or inconsistencies. The data demonstrated frequency performance deficiencies in several procedures, including foot and ocular fundus examination and various cardiovascular screening tests. In contrast, HbA1c and cardiovascular risk factor assessments were performed with a greater frequency than recommended by international guidelines. Management of insulin therapy was sub-optimal, and deficiencies were also noted among diabetes education indicators. Conclusions: Patient registry was successfully implemented in these clinics following an interactive educational program. The data obtained provide useful information as to deficiencies in care and may be used to guide quality of care improvement efforts.
dc.languageeng
dc.publisherWiley
dc.relationInternational Journal of Clinical Practice
dc.relation1742-1241
dc.rightshttps://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
dc.rightsinfo:eu-repo/semantics/restrictedAccess
dc.subjectHumans
dc.subjecthypertension
dc.subjectmajor clinical study
dc.subjectPeru
dc.subjectpriority journal
dc.subjectArgentina
dc.subjectangiotensin receptor antagonist
dc.subjectbeta adrenergic receptor blocking agent
dc.subjectdipeptidyl carboxypeptidase inhibitor
dc.subjecthydroxymethylglutaryl coenzyme A reductase inhibitor
dc.subjectChronic Disease
dc.subjectobesity
dc.subjecthospitalization
dc.subjectHospitalization
dc.subjectstandardization
dc.subjectarticle
dc.subjectDiabetes Mellitus, Type 2
dc.subjectscreening test
dc.subjectColombia
dc.subjecthemoglobin A1c
dc.subjectinsulin
dc.subjectnon insulin dependent diabetes mellitus
dc.subjectoral antidiabetic agent
dc.subjecthealth care quality
dc.subjectcalcium channel blocking agent
dc.subjectpractice guideline
dc.subjectcardiovascular risk
dc.subjectQuality of Health Care
dc.subjecthyperglycemia
dc.subjectRegistries
dc.subjectDelivery of Health Care
dc.subjectdyslipidemia
dc.subjectDyslipidemias
dc.subjectantilipemic agent
dc.subjectcardiovascular procedure
dc.subjectClinical Laboratory Techniques
dc.subjectdiabetes education
dc.subjectdisease registry
dc.subjectdiuretic agent
dc.subjecteye examination
dc.subjectezetimibe
dc.subjectfibric acid derivative
dc.subjectHyperglycemia
dc.subjectinsulin derivative
dc.subjectinsulin treatment
dc.subjectmetformin
dc.subjectPatient Education as Topic
dc.subjectsulfonylurea
dc.titleRegistry of people with diabetes in three Latin American countries: A suitable approach to evaluate the quality of health care provided to people with type 2 diabetes
dc.typeinfo:eu-repo/semantics/article


Este ítem pertenece a la siguiente institución